Since its debut by Novo Nordisk in 2026, it stands as the first oral GLP-1 specifically approved for weight loss, unlike Rybelsus, which targets type 2 diabetes
Interestingly, in GLP-1R-deficient mice, liraglutide loses its beneficial effects (Steven et al., 2017)
It is recommended filtering the buffers by passing them through a 0.22m or 0.45 m filter before use
Semaglutide activates GLP-1 receptors in the hypothalamus and gut, producing 500800 calorie daily deficits through involuntary appetite suppression
This delayed stomach emptyingcalled gastroparesis when it becomes severeis actually what creates the appetite reduction that makes weight loss easier
If someone can tolerate a once-weekly injection, I often recommend that instead